WDR20 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.199000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.681600E-01
Normal-vs-Stage2
5.890000E-01
Normal-vs-Stage3
1.209590E-01
Normal-vs-Stage4
7.389000E-01
Stage1-vs-Stage2
2.215800E-01
Stage1-vs-Stage3
4.319600E-02
Stage1-vs-Stage4
8.003800E-01
Stage2-vs-Stage3
8.358100E-02
Stage2-vs-Stage4
5.026400E-01
Stage3-vs-Stage4
1.782150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.368200E-01
Normal-vs-AfricanAmerican
6.516600E-01
Normal-vs-Asian
6.103600E-01
Caucasian-vs-AfricanAmerican
7.775000E-01
Caucasian-vs-Asian
4.880400E-01
AfricanAmerican-vs-Asian
8.686800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.219200E-01
Normal-vs-Female
7.259400E-01
Male-vs-Female
9.838000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.041400E-01
Normal-vs-Age(41-60Yrs)
8.690800E-01
Normal-vs-Age(61-80Yrs)
5.549000E-01
Normal-vs-Age(81-100Yrs)
3.435000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.352400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.432400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.533040E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.797700E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.616200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.796000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.611400E-01
Normal-vs-Daily Drinker
4.133400E-01
Normal-vs-Weekly Drinker
5.971400E-01
Normal-vs-Occasional Drinker
8.549800E-01
Normal-vs-Social Drinker
9.147400E-01
Non Drinker-vs-Daily Drinker
8.826200E-01
Non Drinker-vs-Weekly Drinker
9.622400E-01
Non Drinker-vs-Occasional Drinker
6.604300E-02
Non Drinker-vs-Social Drinker
2.761600E-01
Daily Drinker-vs-Weekly Drinker
9.530600E-01
Daily Drinker-vs-Occasional Drinker
5.790200E-02
Daily Drinker-vs-Social Drinker
2.483400E-01
Weekly Drinker-vs-Occasional Drinker
1.823390E-01
Weekly Drinker-vs-Social Drinker
4.255200E-01
Occasional Drinker-vs-Social Drinker
6.180200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.120550E-01
Normal-vs-Grade 2
9.584900E-03
Normal-vs-Grade 3
2.314100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.703000E-01
Grade 1-vs-Grade 3
5.081200E-01
Grade 1-vs-Grade 4
1.120550E-01
Grade 2-vs-Grade 3
9.705400E-01
Grade 2-vs-Grade 4
9.584900E-03
Grade 3-vs-Grade 4
2.314100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.886000E-01
Normal-vs-NonDiabetic
7.553800E-01
Diabetic-vs-NonDiabetic
1.201830E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.113600E-02
Normal-vs-NoPancreatitis
7.232800E-01
Pancreatitis-vs-NoPancreatitis
5.504500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.084400E-01
Normal-vs-N1
6.369800E-01
N0-vs-N1
7.690600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.086000E-01
Normal-vs-TP53-NonMutant
9.987000E-01
TP53-Mutant-vs-TP53-NonMutant
7.414400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
